Literature DB >> 13357939

Modification of treatment of schedules in the management of advanced mouse leukemia with amethopterin.

A GOLDIN, S R HUMPHREYS, N MANTEL, J M VENDITTI.   

Abstract

Entities:  

Keywords:  FOLIC ACID ANTAGONISTS/effects; LEUKEMIA/experimental

Mesh：

Substances：

Year:  1956        PMID： 13357939

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  10 in total

Review 1.  An assessment of massive-dose chemotherapy of malignant disease.

Authors:  D E Bergsagel
Journal:  Can Med Assoc J       Date:  1971-01-09       Impact factor: 8.262

2.  Multiclinic trials in cancer chemotherapy.

Authors:  C G Zubrod
Journal:  Can Med Assoc J       Date:  1967-07-15       Impact factor: 8.262

3.  Leukemia in children.

Authors: 
Journal:  Calif Med       Date:  1971-04

4.  New approach to antifolate treatment of certain cancers as demonstrated in tissue culture.

Authors:  R M Halpern; B C Halpern; B R Clark; H Ashe; D N Hardy; P Y Jenkinson; S C Chou; R A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

Review 5.  Contribution of tumoral and host solute carriers to clinical drug response.

Authors:  Jason A Sprowl; Torben S Mikkelsen; Hugh Giovinazzo; Alex Sparreboom
Journal:  Drug Resist Updat       Date:  2012-03-28       Impact factor: 18.500

6.  Cell cycle effects of trimetrexate (CI-898).

Authors:  K E Hook; J M Nelson; B J Roberts; D P Griswold; W R Leopold
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Effects of varying the interval between courses of methotrexate on its myelotoxic and anti-leukaemic activities.

Authors:  B Harding; J Culvenor; I C MacLennan
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

Review 8.  Making the most of rodent tumour systems in cancer drug discovery.

Authors:  M C Bibby
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

9.  Lessons from 20 years of curative therapy of childhood acute leukaemia.

Authors:  D Pinkel
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

10.  The variability of individual tolerance to methotrexate in cancer patients.

Authors:  H H Hansen; O S Selawry; J F Holland; C B McCall
Journal:  Br J Cancer       Date:  1971-06       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.